30th August 2018 - Successful First Batches from Upperton Clinical Manufacturing Plant
Successful First Batches from Upperton Clinical Manufacturing Plant
Upperton has successfully produced its first batches of product from its clinical manufacturing plant during August.
The inaugural batches were:
· Spray dried from solutions containing a range of excipients.
· Spray dried powder was both filled into capsules and tableted.
· Analytical tests including particle sizing, hardness and dissolution testing were performed.
The Upperton GMP manufacturing team were delighted to successfully complete these initial batches and now look forward to further work for an expanding customer base. To initiate discussions and learn more contact Upperton.